All Circulars (28174)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE circular listing securities entering, exiting, and moving between stages in the Short Term Additional Surveillance Measure (ST-ASM) … | |||||||||||||||
BSE circular listing securities entering, exiting, and moving between stages in the Short Term Additional Surveillance Measure (ST-ASM) framework effective January 08, 2026.
| |||||||||||||||
NSE circular announcing inclusion of 6 securities in ST-ASM Stage I framework with increased margin requirements effective January 9, 2026. | |||||||||||||||
NSE circular announcing inclusion of 6 securities in ST-ASM Stage I framework with increased margin requirements effective January 9, 2026.
| |||||||||||||||
Modern Diagnostic & Research Centre Limited equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M … | |||||||||||||||
Modern Diagnostic & Research Centre Limited equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) equity shares will be transferred from Trade for Trade segment (MT Group) … | |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) equity shares will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
Trading in equity shares of MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) will be transferred from Trade for Trade … | |||||||||||||||
Trading in equity shares of MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M … | |||||||||||||||
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED equity shares to be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
| |||||||||||||||
ISIN code change for SKM Egg Products Export (India) Limited effective January 12, 2026 due to equity share sub-division from Rs. 10/- to … | |||||||||||||||
ISIN code change for SKM Egg Products Export (India) Limited effective January 12, 2026 due to equity share sub-division from Rs. 10/- to Rs. 5/-.
| |||||||||||||||
BSE revises price bands for 23 scrips ranging from 2% to 20%, effective January 8, 2026, impacting daily trading limits for affected … | |||||||||||||||
BSE revises price bands for 23 scrips ranging from 2% to 20%, effective January 8, 2026, impacting daily trading limits for affected securities.
| |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner … | |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner facility Pharmathen manufacturing Lanreotide Injection.
| |||||||||||||||